Who
Brian H. Nutt
VP, Chief Accounting Officer
Company insider
Files Form 4 as: VP, Chief Accounting Officer, Omnicell; Principal Accounting Officer, Covance.
In numbers
- Trades disclosed
- 44
- Buys
- 0
- Sells
- 6
- Bought
- $0
- Sold
- $433K
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 20 Feb 2012
- Last trade
- 15 Aug 2026
- Last filed
- 18 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Aug 2026filed 18 Aug 2026 | OMCL OmnicellMedical Devices | SEC FORM 4 Code F | $35K937 at $37.30 | filing |
| 15 Aug 2026filed 18 Aug 2026 | OMCL OmnicellMedical Devices | SEC FORM 4 Code F | $35K937 at $37.30 | filing |
| 15 May 2026filed 19 May 2026 | OMCL OmnicellMedical Devices | SEC FORM 4 Code F | $9,745226 at $43.12 | filing |
| 15 May 2026filed 19 May 2026 | OMCL OmnicellMedical Devices | SEC FORM 4 Code F | $9,745226 at $43.12 | filing |
| 1 Apr 2026filed 3 Apr 2026 | OMCL OmnicellMedical Devices | SEC FORM 4 Code A | —5,556 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | OMCL OmnicellMedical Devices | SEC FORM 4 Code A | —5,556 at $0.00 | filing |
| 15 Feb 2026filed 18 Feb 2026 | OMCL OmnicellMedical Devices | SEC FORM 4 Code F | $9,417258 at $36.50 | filing |
| 15 Feb 2026filed 18 Feb 2026 | OMCL OmnicellMedical Devices | SEC FORM 4 Code F | $9,417258 at $36.50 | filing |
| 15 Aug 2025filed 19 Aug 2025 | OMCL OmnicellMedical Devices | SEC FORM 4 Code F | $22K681 at $31.69 | filing |
| 15 Aug 2025filed 19 Aug 2025 | OMCL OmnicellMedical Devices | SEC FORM 4 Code A | —7,663 at $0.00 | filing |
| 15 May 2025filed 19 May 2025 | OMCL OmnicellMedical Devices | SEC FORM 4 Code F | $8,368298 at $28.08 | filing |
| 15 Aug 2024filed 19 Aug 2024 | OMCL OmnicellMedical Devices | SEC FORM 4 Code A | —6,647 at $0.00 | filing |
| 15 May 2024filed 17 May 2024 | OMCL OmnicellMedical Devices | SEC FORM 4 Code A | —3,218 at $0.00 | filing |
| 15 Nov 2015filed 18 Nov 2025 | OMCL OmnicellMedical Devices | SEC FORM 4 Code F | $7,937226 at $35.12 | filing |
| 19 Feb 2015filed 23 Feb 2015 | Covance | SEC FORM 4 Code D | —1,655 | filing |
| 19 Feb 2015filed 23 Feb 2015 | Covanceoption or derivative | SEC FORM 4 Code D | —378 | filing |
| 22 Dec 2014filed 23 Dec 2014 | Covance | SEC FORM 4 Code M | $44K750 at $58.37 | filing |
| 22 Dec 2014filed 23 Dec 2014 | Covance | SEC FORM 4 Code M | $18K377 at $48.16 | filing |
| 22 Dec 2014filed 23 Dec 2014 | Covance | SEC FORM 4 Sold | $117K1,127 at $103.51 | filing |
| 22 Dec 2014filed 23 Dec 2014 | Covanceoption or derivative | SEC FORM 4 Code M | —750 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.